肿瘤学创新(英文)2025,Vol.4Issue(4):25-35,11.DOI:10.1002/cai2.70014
Prediction of Therapeutic Response and Prognosis in Ovarian Cancer Patients With Plasma Circulating Biomarkers
Prediction of Therapeutic Response and Prognosis in Ovarian Cancer Patients With Plasma Circulating Biomarkers
摘要
关键词
circulating tumor DNA/copy number alterations/ovarian cancer/TP53 mutationsKey words
circulating tumor DNA/copy number alterations/ovarian cancer/TP53 mutations引用本文复制引用
Haixia Cheng,Yuchen Jiao,Mei Liu,Lingying Wu,Guangwen Yuan,Leilei Liang,Tiantian Wang,Jiarun Zhu,Hongying Yang,Zhendiao Zhou,Pei Wang,Qianqian Song..Prediction of Therapeutic Response and Prognosis in Ovarian Cancer Patients With Plasma Circulating Biomarkers[J].肿瘤学创新(英文),2025,4(4):25-35,11.基金项目
This study was partly supported by the National Key R&D Program of China(Grant No.2016YFC13037040)and the Nonprofit Central Research Institute Fund of the Chinese Academy of Medical Sciences(Grant No.2022-RC310-08). (Grant No.2016YFC13037040)